Aardvark Therapeutics, Inc. Common Stock (AARD) ownership: Top institutional holder: Decheng Capital LLC ($14.77M). Insider activity: Net Seller (8 buys, 12 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Decheng Capital LLC | 3917299.00 | $14.77M | 2026-03-31 |
| VANGUARD GROUP INC | 717430.00 | $9.42M | 2025-12-31 |
| SymBiosis Capital Partners, LLC | 476595.00 | $6.26M | 2025-12-31 |
| CITADEL ADVISORS LLC | 1242777.00 | $4.69M | 2026-03-31 |
| Laurion Capital Management LP | 1034459.00 | $3.90M | 2026-03-31 |
| BlackRock, Inc. | 792571.00 | $2.99M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 554101.00 | $2.09M | 2026-03-31 |
| Tetragon Partners GP Ltd | 316621.00 | $1.19M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-02-09 | |
| Sell | null | 2026-02-09 | |
| Sell | null | 2026-02-09 | |
| Sell | null | 2026-02-09 | |
| Sell | null | 2026-02-09 | |
| Sell | null | 2026-02-09 | |
| Buy | null | 2025-12-11 | |
| Buy | null | 2025-12-11 |
Back to AARD overview · AARD earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.